卖什么
Authoring documents for life sciences in minutes, not months.
商业模式拆解
买家：谁掌握预算？
未核实Regulatory and medical writing teams at biopharma companies.
触发点：什么让他们现在购买？
Need to produce INDs, NDAs and BLAs and their component documents faster and more cheaply.
工作流：什么输入变成什么输出？
Generate first drafts of regulatory documents (clinical study reports, clinical/non-clinical overviews, summaries, IBs) from source data using purpose-built AI and templates, regenerate sections, track data across documents, then publish.
渠道：怎么接触到客户？
Demo-led ("Book Demo"), events and community.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2024 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.